Free shipping on all orders over $ 500

Preladenant

Cat. No. M9345

All AbMole products are for research use only, cannot be used for human consumption.

Preladenant Structure
Synonym:

SCH-420814

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
1mg USD 33  USD33 In stock
2mg USD 47  USD47 In stock
5mg USD 75  USD75 In stock
10mg USD 125  USD125 In stock
25mg USD 217  USD217 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Preladenant is a potent and competitive antagonist of the human adenosine A2A receptor with a Ki of 1.1 nM. Preladenant also completely antagonizes cAMP in cells expressing the recombinant human A2A receptor.

Preladenant (1 mg/kg) inhibits L-Dopa-induced behavioral sensitization after repeated daily administration, which suggests a reduced risk of the development of dyskinesias. Preladenant exhibits antidepressant-like profiles in models of behavioral despair, namely the mouse tail suspension test and the mouse and rat forced swim test. Preladenant produces a dose-dependent reduction in parkinsonian scores at doses of 1 mg/kg (min score: 9.0) and 3 mg/kg (min score: 6.5). A subthreshold dose of Preladenant reduces minimum and mean parkinsonian scores in animals treated with 3 mg kg of L-Dopa to 5.25 and 6.88 respectively. A Wilcoxin test is used to compare individual treatments against vehicle. Preladenant (3 mg/kg), L-Dopa (3, 6, and 12 mg/kg), and the combination of Preladenant and L-Dopa (1 or 3 mg/kg+3 mg/kg) are all significantly improved on the minimum parkinsonian score. In addition, both the 12 mg/kg L-Dopa and L-Dopa+Preladenant groups are significantly improved on both minimum and mean parkinsonian scores relative to the 3 mg/kg L-Dopa group.

Chemical Information
Molecular Weight 503.56
Formula C25H29N9O3
CAS Number 377727-87-2
Solubility (25°C) DMSO 2.5 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Z Wang, et al. Preladenant, a selective adenosine A₂A receptor antagonist, is not associated with QT/QTc prolongation

[2] John D Salamone. Preladenant, a novel adenosine A(2A) receptor antagonist for the potential treatment of parkinsonism and other disorders

Related Adenosine Receptor Products
SYN115

Tozadenant (SYN115) is a novel, selective adenosine A(2A) receptor antagonist.

CGS 21680 hydrochloride

CGS 21680 hydrochloride is an A2A adenosine receptor agonist with an Ki of 27 nM.

Istradefylline

Istradefylline (KW-6002) is a potent, selective and orally active adenosine A2A receptor (A2AR) antagonist with Ki of 2.2 nM.

CGS 21680

CGS 21680 is a selective adenosine receptor agonist for A2A and A3 with Ki of 15 ng/mL and 37 ng/mL, respectively.

Norisoboldine

Norisoboldine is an isoquinoline alkaloid which acts as an AhR agonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: Preladenant, SCH-420814 supplier, Adenosine Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.